The GEO Group, Inc. (GEO) AI Stock Analysis

NYSE: GEOAI research summary: business, growth, valuation, analysts, bull and bear case.

GEO AI stock analysis summary

AI Research

The GEO Group, Inc. (NYSE: GEO) is a government services provider specializing in secure facilities, processing centers, and community reentry programs across the United States, Australia, South Africa, and the United Kingdom. TTM revenue reached $2.83B with a profit margin of 10.3%, while quarterly earnings grew 71.4% year-over-year in the latest quarter ending June 30, 2026. The stock trades at a trailing P/E of 13.5x with a 1-year return of 71.2%.

Market cap
$3.77B
Revenue (TTM)
$2.83B
P/E
13.5x
fwd 19.0x
1Y return
71.2%
S&P 500 16.8%
Avg. target
$39.00
36.1% vs last close

Bull case

  • Quarterly earnings jumped 71.4% year-over-year in the period ended June 30, 2026, accompanied by 15.1% revenue growth.
  • GEO trades at an EV/EBITDA of 8.2x and a trailing P/E of 13.5x, both well below the US-listed Industrials medians of 13.9x and 24.8x.
  • All 3 covering analysts rate the stock a Strong Buy, with a mean price target of $39.00 implying 36.1% upside.

Bear case

  • Free cash flow dropped to -$124.9M in FY2025 as operating cash flow declined to $72.6M alongside $197.5M in capital expenditures.
  • The company holds total debt of $1.61B against just $57.1M in cash and short-term investments, resulting in net debt of $1.55B.
  • Forward P/E sits at 19.0x, representing a premium over the US-listed Industrials peer median of 17.2x.

What GEO does

The GEO Group, Inc. is a provider of diversified government services specializing in the design, financing, development, and support of secure facilities, processing centers, and community reentry programs across the United States, Australia, South Africa, and the United Kingdom. Its service suite spans in-custody rehabilitation, post-release support through the GEO Continuum of Care, secure transportation, electronic monitoring, community-based programs, and correctional health and mental health care solutions. The company manages a portfolio encompassing ownership and operational support for 102 facilities totaling approximately 82,000 beds, supported by approximately 18,000 employees.

Growth and profitability

Between FY2021 and FY2025, annual revenue expanded from $2.26B to $2.63B, reflecting a 5-year revenue CAGR of 2.3%. FY2025 revenue grew 8.6%, with net income rising to $254.4M and net margin at 9.7%, up from $32.0M and 1.3% in FY2024. Operating margins fluctuated across the period, landing at 9.8% in FY2025 compared to 16.2% in FY2022. For the trailing twelve months, revenue was $2.83B with an operating margin of 13.9% and diluted EPS of $2.13. In the quarter ended June 30, 2026, quarterly revenue grew 15.1% year-over-year while quarterly earnings surged 71.4%.

GEO income statement →

Balance sheet and cash flow

As of June 30, 2026, The GEO Group held $57.1M in cash and short-term investments against total debt of $1.61B, leaving net debt at $1.55B. Shareholders' equity was $1.52B, resulting in a debt-to-equity ratio of 1.06 and a current ratio of 1.65. Operating cash flow fell to $72.6M in FY2025 from $242.2M in FY2024, while free cash flow was -$124.9M after accounting for $197.5M in capital expenditures. Cash deployment in FY2025 also included $91.0M spent on share buybacks, though share count expanded 9.5% over 5 years.

GEO balance sheet →

Valuation and performance

At $28.66 per share, GEO carries a market capitalization of $3.77B and an enterprise value of $5.58B. It trades at a trailing P/E of 13.5x and an EV/EBITDA of 8.2x, below the median of its US-listed Industrials peers at 24.8x and 13.9x, respectively. Its forward P/E of 19.0x stands above the peer median of 17.2x, alongside a price-to-sales multiple of 1.3x and price-to-book of 2.7x. The stock returned 71.2% over the past year and 244.9% over five years, outperforming the S&P 500 (SPY) benchmarks of 16.8% and 83.0% over the identical timeframes.

GEO key metrics →

What analysts expect

Wall Street sentiment is unanimous across tracked analysts, with 3 Strong Buy ratings and no Buy, Hold, or Sell ratings. The mean price target of $39.00 indicates an implied upside of 36.1% relative to the closing price of $28.66 on October 16, 2026. For the current fiscal year ending December 31, 2026, consensus calls for revenue of $2.99B and EPS of $1.31, representing 52.0% EPS growth. In the following fiscal year, 4 analysts estimate revenue of $3.26B and EPS of $1.72. GEO beat EPS estimates in 3 of the last 4 quarters, with next earnings scheduled for November 5, 2026.

GEO forecast and price target →

Key risks and what to watch

  • The debt-to-equity ratio stands at 1.06 with $1.61B in total debt, creating exposure to debt refinancing and interest costs.
  • Negative free cash flow of -$124.9M in FY2025 limits balance sheet flexibility if operating cash flow remains pressured.
  • Short interest accounts for 10.5% of float, pointing to meaningful negative sentiment among market participants.

AI-generated research summary. Written with AI from Quotelinks data as of October 16, 2026 and checked so every figure matches that data. For information only, not investment advice. Disclaimer

About this GEO AI stock analysis

This page is an AI-written research summary of The GEO Group, Inc. (GEO). The text was generated on October 30, 2026 from Quotelinks data as of October 16, 2026 (company profile, annual results, latest balance sheet, valuation, price performance and analyst estimates). An automatic check rejects any draft that contains a figure not found in that data. It is not investment advice; verify figures on the linked tabs before making decisions.

Related: GEO income statement, GEO balance sheet, GEO key metrics, GEO analyst forecast, GEO chart. See the GEO stock overview for the latest quote and news.

GEO AI stock analysis FAQ

What is The GEO Group's core business?

The company provides government-oriented secure facilities, processing centers, and community reentry programs across the US, Australia, South Africa, and the UK. It manages 102 facilities totaling about 82,000 beds, offering rehabilitation, healthcare, electronic monitoring, and secure transportation.

Does The GEO Group pay a dividend?

GEO currently does not pay a dividend based on the provided report data.

What are analysts forecasting for GEO's earnings?

Analysts forecast FY2026 EPS of $1.31 on revenue of $2.99B, which would represent 52.0% earnings growth. For FY2027, 4 analysts expect EPS of $1.72 on revenue of $3.26B.

How leveraged is The GEO Group's balance sheet?

As of June 30, 2026, GEO had $1.61B in total debt and $57.1M in cash, leading to net debt of $1.55B. Its debt-to-equity ratio is 1.06 and its current ratio is 1.65.

More Industrials AI stock analysis